Chemistry of mangana- and rhenatricarbadecaboranyl tricarbonyl complexes: evidence for an associative mechanism of ligand substitution involving an eta6-eta4 cage-slippage process analagous to eta5-eta3-cyclopentadienyl ring-slippage.

The reaction of the tricarbadecaboranyl anion, 6-Ph-nido-5,6,9-C(3)B(7)H(9)(-), with M(CO)(5)Br [M = Mn, Re] or [(eta(6)-C(10)H(8))Mn(CO)(3)(+)]BF(4)(-) yielded the half-sandwich metallatricarbadecaboranyl analogues of (eta(5)-C(5)H(5))M(CO)(3) [M = Mn, Re]. For both 1,1,1-(CO)(3)-2-Ph-closo-1,2,3,4-MC(3)B(7)H(9) [M = Mn (2) and Re (3)], the metal is eta(6)-coordinated to the puckered six-membered open face of the tricarbadecaboranyl cage. Reactions of 2 and 3 with isocyanide at room temperature produced complexes 8-(CNBu(t))-8,8,8-(CO)(3)-9-Ph-nido-8,7,9,10-MC(3)B(7)H(9) [M = Mn (4), Re (5)], having the cage eta(4)-coordinated to the metal.

Synthesis and structural characterization of symmetrical closo-4,7-I2-1,2-C2B10H10 and [(CH3)3NH][nido-2,4-I2-7,8-C2B9H10].

The boron-atom insertion reaction of nido-9,11-I(2)-7,8-C(2)B(9)H(9)(2-), with the HBCl(2):SMe(2) complex yields closo-4,7-I(2)-1,2-C(2)B(10)H(10), 1, in excellent yield. Although the two boron atoms (B3 and B6) nearest to the carbon atoms in 1 are equally available for attack by nucleophiles, the boron-degradation reaction of 1 with alkoxide ion occurs only at the B6 vertex, yielding regioselectively [(CH(3))(3)NH][nido-2,4-I(2)-7,8-C(2)B(9)H(10)], 2. The molecular structures of 1 and 2 have been determined by X-ray diffraction studies.

Syntheses of functionalized ferratricarbadecaboranyl complexes.

The reactions of nitriles (RCN) with arachno-4,6-C(2)B(7)H(12)(-) provide a general route to functionalized tricarbadecaboranyl anions, 6-R-nido-5,6,9-C(3)B(7)H(9)(-), R = C(6)H(5) (2(-)), NC(CH(2))(4) (4(-)), (p-BrC(6)H(4))(Me(3)SiO)CH (6(-)), C(14)H(11) (8(-)), and H(3)BNMe(2)(CH(2))(2) (10(-)). Further reaction of these anions with (eta(5)-C(5)H(5))Fe(CO)(2)I yields the functionalized ferratricarbadecaboranyl complexes 1-(eta(5)-C(5)H(5))-2-C(6)H(5)-closo-1,2,3,4-FeC(3)B(7)H(9) (3), 1-(eta(5)-C(5)H(5))-2-NC(CH(2))(4)-closo-1,2,3,4-FeC(3)B(7)H(9) (5), 1-(eta(5)-C(5)H(5))-2-[(p-BrC(6)H(4))(Me(3)SiO)CH]-closo-1,2,3,4-FeC(3)B(7)H(9) (7), 1-(eta(5)-C(5)H(5))-2-C(14)H(11)-closo-1,2,3,4-FeC(3)B(7)H(9) (9), and 1-(eta(5)-C(5)H(5))-2-H(3)BNMe(2)(CH(2))(2)-closo-1,2,3,4-FeC(3)B(7)H(9) (11). Reaction of 11 with DABCO (triethylenediamine) resulted in removal of the BH(3) group coordinated to the nitrogen of the side chain, giving 1-(eta(5)-C(5)H(5))-2-NMe(2)(CH(2))(2)-closo-1,2,3,4-FeC(3)B(7)H(9) (12).

Cytotoxicity and mode of action of vanada- and niobatricarbadecaboranyl monohalide complexes in human HL-60 promyelocytic leukemia cells.

Vanada- and niobatricarbadecaboranyl monohalide complexes proved to be potent cytotoxic agents against murine and human leukemia and lymphoma growth as well as HeLa suspended uterine carcinoma. The vanada complex reduced the growth of KB nasopharynx, Hepe liver, HCT-8 ileum and 1-A9 ovary solid carcinomas. A mode of action study in human HL-60 promyelocytic leukemia cells showed that DNA and purine de novo syntheses were significantly inhibited with suppression of the regulatory enzymes activities of DNA polymerase alpha and PRPP-amido transferase.